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Interpreting the 1996 Federal Antitrust
Guidelines for Physician Joint
Venture Networks
Edward Hirshfeld*
INTRODUCTION

The Statements of Antitrust Enforcement Policy in Health Care
("Statements")' issued by the Federal Trade Commission2
("FTC") and the United States Department of Justice ("DOJ")
on August 28, 1996, made dramatic changes in how these agencies evaluate the legality of physician joint venture networks
under federal antitrust laws.3 These changes are important to
* Mr. Hirshfeld is vice president and associate general counsel of the American
Medical Association. He received his Bachelor of Arts from Harvard University, and
his Juris Doctor and Master of Business Administration from Cornell University.
Prior to serving the AMA, he was a partner with Gardner, Carton & Douglas in
Chicago, Illinois.
The author gratefully thanks Sanja Sharma, J.D., from Loyola University Chicago
School of Law for his assistance with research for this article.

1. U.S. DEP'T OF JUSTICE & FED. TRADE COMM'N, STATEMENTS OF ANTITRUST
ENFORCEMENT POLICY IN HEALTH CARE (1996) [hereinafter STATEMENTS] (consisting of nine Statements that address different subject areas). This article will refer to
individual Statements by number, for example, "Statement Eight," and will cite to
pages in the officially released version. The Statements can be found at the DOJ web
sites, gopher@justice.usdoj.gov or http://www.usdoj.gov; the FTC web site is at http://
www.ftc.gov.
2. The FTC and DOJ will be referred to collectively as "the agencies."

3.

The changes were made to the

STATEMENTS OF ENFORCEMENT POLICY AND

issued by
the DOJ and FTC on September 27, 1994 (the "1994 Statements"). The 1994 version
revised the STATEMENTS OF ANTITRUST ENFORCEMENT POLICY FOR THE HEALTH
CARE AREAS, issued in September, 1993 (the "1993 Statements"). Page citations will
be to the officially released versions of these documents.
The Statements are enforcement policies only and not laws. While courts are not
obligated to follow them, they usually regard the enforcement policies of the DOJ
and FTC as persuasive authority and often do follow them. In addition, the Statements are regarded as authoritative by the health care industry due to the absence of
case law on the subjects addressed in the Statements and due to the threat of enforcement actions by the agencies if a physician joint venture network transgresses the
Statements. Both agencies have very active enforcement programs for the health care
industry. For a summary of these actions, see Gail Kursh, Chief, Health Care Task
Force, U.S. Dep't of Justice, Update on Antitrust Division Health Care Enforcement
Activities, Address Before the National Health Law. Ass'n (Feb. 13, 1997) in NAANALYTICAL PRINCIPLES RELATING TO HEALTH CARE AND ANTITRUST,

TIONAL HEALTH LAW. ASS'N, ANTITRUST IN THE HEALTHCARE FIELD

(1997), and

Robert F. Leibenluft, Assistant Director, Bureau of Competition, Federal Trade
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the medical profession because they remove antitrust enforceformation of physician
ment policies that were barriers to the
4
joint venture networks ("networks").
Network formation is important to physicians as a strategy for
adapting to managed care. A network enables physicians to offer to managed care health plans5 a package of high-quality
medical services in a defined geographic area at a competitive
cost. Health plans are often willing to work with networks because networks can assume some of the plan's functions, such as
recruiting physicians and managing medical care.6 By assuming
these functions, network physicians can have greater control
over patient care, which is important to a physician's sense of
professional mission. In addition, health plans will want to contract with networks that perform these functions well, allowing
the network physicians to prosper economically.
The nine Statements facilitate network development in two
ways. First, they provide specific criteria for certain types of
networks considered to be legal. Networks that meet these criteria fall within an "antitrust safety zone"-the agencies will not
investigate or challenge the legality of these networks except in
extraordinary circumstances. Physicians organizing networks
that fall within these antitrust safety zones can be confident that
they will not be challenged by the agencies. 7
Comm'n, FTC Antitrust Actions in Health Care Services (Jan. 1997) (on file with the
author). The 1993 and 1994 Statements were widely regarded as authoritative and had
a major impact on the decisions of physicians and their attorneys in network
formation.
4. The Statements define a network as an independent practice association
("IPA"), a preferred provider organization ("PPO"), or a substantively equivalent
arrangement that is designed to market the services of the participating physicians to
health plans. STATEMENTS, supra note 1, at 61 n.22, 62, 106. When physicians participate in networks, they typically continue to compete with each other for patients who
are not enrolled in the network. This distinguishes the network from a fully integrated group practice, where the physicians are partners, shareholders, or employees,
and do not compete with each other.
5. In this article, "health plan" refers to a broad range of payers, including health
maintenance organizations, preferred provider organizations, point-of-service plans,
traditional indemnity health insurance plans, self-funded employer plans, and others.
6. Assumption of these functions by networks is particularly useful to payers who
do not want to invest in them (such as self-funded employers) or who are trying to
enter a new market and need to recruit highly regarded physicians while minimizing
the cost of assembling a physician network.
7. The agencies say they will not challenge networks that fall within the safety
zones "absent extraordinary circumstances." STATEMENTS, supra note 1, at 64-65.
While to date the agencies have not challenged a network that was in a safety zone,
they have disagreed with parties about whether a proposed network would be in a
safety zone. For example, in one business review letter, the DOJ disagreed with phyhttp://lawecommons.luc.edu/annals/vol6/iss1/3
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Second, the Statements say that many networks outside the
safety zones are likely to be legal, although they do not provide
specific criteria by which these networks can be identified. Instead, such networks are subject to agency review to determine
whether they are legal; the Statements describe the review process and the factors considered in reaching a decision about the
legality of a network. This review process is deliberately flexible, as the agencies are not confident that they can describe the
exact characteristics of every type of network that is legal or
illegal, and, given the many network variations, the agencies do
not want to chill the development of networks that would be
beneficial to the market, nor allow networks that are
anticompetitive.
Because of the lack of specificity in the Statements about
when networks outside the safety zones are legal, evaluating the
legality of such a network requires the exercise of judgment.
Now that physicians and their attorneys have been working with
the Statements for almost one year, questions have arisen about
how to interpret key aspects of the Statements in order to make
these judgments. It is important that these questions be addressed, because uncertainty can chill efforts to organize
networks.
Interpreting the Statements and making judgments with confidence requires familiarity with the fundamental antitrust principles underlying the Statements, and familiarity with how the
agencies are applying these principles in the Statements. Part I
of this article will summarize the fundamental principles of federal antitrust law through an analysis of joint ventures under the
antitrust laws. Part II will then explain how the Statements apply these principles. Finally, part III will specifically address the
major questions of interpretation that are being raised.
In summary, part III will answer four questions. First, is there
an availability of simple networks? Many physicians think that
the Statements make network development impractical, believing that the Statements require sophisticated networks where
the physicians assume risk, such as capitation arrangements, or,
if on a fee-for-service basis, require that the physicians be highly
sicians that their proposed network would be in a safety zone, warning that the network might violate the antitrust laws if it was formed. Letter from Anne K.
Bingaman, Assistant Attorney Gen., Antitrust Div., Dep't of Justice, to Tad R. Callis-

ter, Calister & Callister, Glendale, Cal., concerning the Orange Los Angeles Medical
Group (Mar. 8, 1996).
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integrated. Many physicians feel that such networks require a
degree of investment, expertise, time, and political consensus
that they cannot muster. However, the Statements allow the
formation of a "messenger model" network that requires only a
modest investment, is simple to operate, does not cause political
tension within a physician community, can accomplish many of
the functions that are needed from a network, and is available to

most physician communities."
Second, what constitutes clinical integration?

Statement

Eight allows fee-for-service networks9 to operate where the participating physicians agree on the fees that they will charge
through the network. However, if such networks are not clinically integrated, their price agreement will be viewed as price
fixing, which is per se illegal. 10 The Statement offers some guidance on what constitutes clinical integration, but not enough to
convey a solid understanding of the concept. While some attorneys argue that a multimillion dollar investment in a management infrastructure, such as computer-based medical
information systems, is necessary to achieve clinical integration,

these investments are not required to achieve clinical integration, and this type of network is within the grasp of many physician communities.
Third, what percentage of a specialty market can join the network? The agencies are interested in the percentage of physi-

cians within a particular specialty who make up the network.
Statement Eight creates an antitrust safety zone for networks
that meet certain specialty concentration percentages, as well as
other criteria." The Statement emphasizes that networks with
8. The messenger model is described in Statement Nine, STATEMENTS, supra note
1, at 125-27, and hypotheticals applying this model follow Statement Nine, id. at 13840, and follow Statement Eight, id. at 102-05.
9. It is important to distinguish between the way a network is paid by a health
plan, and the way the network pays the participating physicians. For example, a network that takes capitation may pay some or all of its participating physicians on a feefor-service basis. STATEMENTS, supra note 1, at 69-70 n.33. In Hassan v. Independent
PracticeAssocs., Inc., 698 F. Supp. 679 (E.D. Mich. 1988), the court found a network
that took capitation from a health maintenance organization and paid its physicians
pursuant to a fee-withholding arrangement to be legal.
10. The Statements allow networks that use certain managerial techniques to enhance quality and reduce costs other than risk sharing to be evaluated by the rule of
reason. STATEMENTS, supra note 1, at 72-73. While the text of the Statements does
not refer to these activities as constituting clinical integration, Hypothetical One at
the end of Statement Eight and Hypothetical One at the end of Statement Nine use
the term in their titles, and antitrust attorneys have begun using that term.
11. Id. at 64-70.
http://lawecommons.luc.edu/annals/vol6/iss1/3
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greater concentrations than the limits will be reviewed under the
rule of reason and can be legal,12 and provides some guidance
about the conditions under which the agencies will consider
these networks to be lawful. 13 However, the Statement's guidance is not clear, thereby leaving uncertainty for larger
networks.
Fourth, are there any opportunities for direct contracting?
Before the Statements were issued, networks that wanted to directly contract with self-funded employers 4 found themselves
caught between the demands of two sets of laws. If they wanted
to contract on a fee-for-service basis, they would likely be engaged in price fixing in violation of the federal antitrust laws. If
they avoided this by entering into capitation arrangements, they
could be subject to state insurance regulation. 5 The Statements
have resolved this problem in two ways. First, they allow feefor-service networks with clinical integration 6 to be formed,
which enables fee-for-service direct contracting arrangements.
Second, they create a new category of substantial financial risk.
There has been uncertainty over the meaning and purpose of
this category of substantial financial risk. It allows a network to
contract with a self-funded employer on a fee-for-service basis
12. Id. at 63, 77-78.
13. Id.; see also the hypotheticals, id. at 83-105.
14. Self-funded employers do not purchase health insurance for their employees.
They pay for the health care expenses of their employees as they arise. However,
they often hire insurance companies or entrepreneurs known as "third-party administrators" to administrate their health benefit plans. These arrangements often appear
to be insured benefits plans to the employees and the providers who treat them. The
benefits plan of a self-funded employer is exempt from state regulation under the
Employee Retirement Income Security Act of 1974, 29 U.S.C. § 1144 (1994) ("ERISA"). It is estimated that over 50% of employed Americans receive their health
coverage from an exempt, self-funded plan. American Med. Ass'n, Direct Contracting
With Employers: A Strategy to Increase Physician Involvement in the Current Health
Care Market, in HousE OF DELEGATES PROCEEDINGS, 144TH ANNUAL MEETING 28

(June 18-22, 1995) (on file with the author).
15. The extent to which self-funded plans are exempt from state laws is a continuing source of controversy. Particularly controversial is whether ERISA exempts risksharing arrangements between self-funded plans and providers. Most insurers, most
state insurance commissioners, and the National Association of Insurance Commissioners ("NAIC") argue that ERISA does not exempt such arrangements because
they amount to the transfer of risk and the spreading and sharing of risk, and therefore constitute the sale and purchase of insurance. For the NAIC position, see the
comments of Kenney Shipley, Chair of the Health Plan Accountability Working
Group, in Insurance Regulation: NAIC Bulletin to Address Application of Insurance
Laws to ProviderGroups,3 BNA's HEALTH CARE POL'Y REP. 32 (Aug. 7, 1995). For
an overview of this controversy, see Allison Overbay & Mark Hall, InsuranceRegulation of Providers That Bear Risk, 22 AM. J. L. & MED. 361 (1996).
16. See supra, note 10.
Published by LAW eCommons, 1997
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and to be eligible for a reward if it meets budgetary goals, enabling a network to realize many of the benefits of full-risk or
global capitation; 17 since it is not subject to downside risk, it
need not acquire an insurance license. Further, a network using
this technique can qualify for a safety zone if it falls within
safety zone specialty concentration limits.
The Statements provide physicians with opportunities to create networks otherwise subject to review. However, they also
create new questions, which in time, hopefully, will be clarified.
I.

ANALYSIS OF JOINT VENTURES UNDER THE

ANTITRUST LAWS

A network is a form of a joint venture. To understand the
1996 guidelines, it is best to have some familiarity with how joint
ventures are evaluated for legality under the antitrust laws.
A. Standards for Proof of Conduct that Violates the
Antitrust Laws
Antitrust laws are meant to preserve competition in a market.
They regulate cooperative activities among participants in a
market to preserve and enhance competition. Some types of cooperative activities violate the antitrust laws because they harm
competition, while other types are not violative because they enhance or do not harm competition. Joint ventures are a type of
cooperative activity that could either enhance or harm competition. The antitrust laws distinguish between cooperative activi17. Full-risk capitation is the assumption of risk by primary care physicians for all
physician services, including those which they cannot directly deliver. The primary
care physicians must contract with other specialist physicians for those services that
they cannot deliver; they profit if the amount that they receive in capitation for the
services involved is greater than the amount that they have to pay the other specialist
physicians for the services involved. PETER BOLAND, THE CAPrrATION SOURCEBOOK

107 (1996); see also Frances H. Miller, Capitationand Physician Autonomy: Master of
the Universe or Just Another Prisoner'sDilemma (What Can Britain's NationalHealth
Service Experience Teach Us?), 6 HEALTH MATRix 89, 92-95 (1996). Global capitation exists when a network takes risk for most, if not all, of the benefits package. For
example, a physician network is engaged in global capitation when it assumes risk for
hospital services as well as physician services. BOLAND, supra at 113. If it costs the
network less than the capitation amount to arrange for hospital services, the network
profits. Full-risk and global capitation give the capitated provider an incentive to
minimize the use of services of the other providers for which it assumes risk. Typically, the providers given full-risk or global capitation are in a position to manage the
use of those services. For example, primary care physicians can control referrals to

specialists, and specialists control many of the hospital admissions and services provided within the hospital.
http://lawecommons.luc.edu/annals/vol6/iss1/3

6

1997]

Antitrust
Hirshfeld: Interpreting
the 1996Guidelines
Federal Antitrust Guidelines for Physician

ties, including joint ventures, that enhance competition and are
legal, and those that are illegal because they harm competition.
Cooperative arrangements among competitors or among
other participants in a market that unreasonably restrain competition are illegal. Restraints are unreasonable if they have a
material adverse effect on competition in a market. Most restraints are evaluated in light of two tests, illegal per se and rule
of reason. First, certain cooperative arrangements are always illegal (illegal per se) regardless of whether there is proof that the
offense actually had an adverse impact on competition in the
market involved. This kind of conduct is considered to be so
threatening to competition that it is automatically illegal. A violation is shown by the fact of the conduct-nothing more needs
to be proven to declare it illegal. Second, cooperative arrangements that are not illegal per se are evaluated for legality under
the rule of reason. Such arrangements are not automatically
deemed illegal. The object of the rule of reason analysis is to
determine whether the arrangement in fact had or is likely to
have a material adverse effect on competition in the market,
Therefore, proving the fact of the cooperative arrangement is
not enough to prove a violation. All relevant factors in the market are reviewed to determine whether the restraint is, on balance, materially anticompetitive.
Antitrust offenses especially relevant to network formation
include price fixing, a group boycott or concerted refusal to
deal, and a division of markets.
Price fixing occurs when two or more independent competitors in a market agree about the prices that each will charge to
third parties. When a group of independent, competing physicians agrees on the fees that they will charge to a health plan,
they engage in price fixing. This offense is illegal per se. 19
A group boycott or concerted refusal to deal is an agreement
between two or more independent competitors not to deal with
a third party. It can also be an agreement between an independent buyer and a seller not to deal with a third party. Some
group boycotts are illegal per se, especially those that are
designed to support a price-fixing agreement or keep firms out
18.

The rule of reason is a structured process used to make that evaluation. It

requires the agency or court to define the
the purpose of the restraint, evaluate its
volved, and determine whether there are
weigh its adverse effects on competition.
19. Arizona v. Maricopa County Med.
Published by LAW eCommons, 1997
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of a market. For example, an agreement among independent
competing physicians to boycott HMOs that do not accept their
agreed-upon fee schedule or to boycott HMOs altogether to
keep them out of the market is per se illegal. Other types of
boycotts are examined under the rule of reason.
A division of markets is an agreement among competitors in a
market dividing the market into segments and agreeing that
they will not compete outside their respective segments; the
agreement is illegal per se. For example, if the physicians on the
east side of town agree with the physicians on the west side of
town that the east siders will not accept patients from the west
side and vice versa, they have created an illegal horizontal division of markets.
B. Exceptions to the Per Se Illegal Analysis
Federal case law has established an exception to the rule that
price fixing, division of markets, and certain group boycotts are
illegal per se, 20 allowing a joint venture to be evaluated under
the rule of reason to determine its actual effect on competition.
The rule of reason is used to evaluate the conduct because the
efficiencies of the cooperative activity may benefit consumers
more than the detriments caused by the reduced competition
will harm consumers.
20. The Supreme Court has applied the rule of reason to normally per se illegal
restraints when it found joint ventures that created essentially a new product or established new efficiencies through integration. Broadcast Music, Inc. v. Columbia
Broadcasting Sys., 441 U.S. 1, 21-23 (1979). Most importantly, the Court has noted

that not all joint ventures that have an impact on price are per se violations of the
Sherman Act. Id. at 23. The Court has also realized that certain industries require

horizontal restraints in order to produce a particular product. National Collegiate
Athletic Ass'n v. Board of Regents of Univ. of Okla., 468 U.S. 85, 100 (1984). Addi-

tionally, the Court has recognized that it cannot always describe the types of business
activities that should automatically fall into the forbidden per se category. Northwest
Wholesaler Stationers, Inc. v. Pacific Stationery & Printing Co., 472 U.S. 284, 294

(1985). Finally, the Court expressed its unwillingness to adhere to a rigid per se analy-

sis where the economic impact of particular activities is not immediately clear. Federal Trade Comm'n v. Indiana Fed'n of Dentists, 476 U.S. 447, 459 (1986).

Many appellate court decisions have supported the Court's reluctance to adhere to
a summary condemnation of certain business practices. See, e.g., Polk Bros., Inc. v.
Forest City Enters., Inc., 776 F.2d 185 (7th Cir. 1985); National Bancard Corp.
(NaBanco) v. VISA U.S.A., Inc., 779 F.2d 592 (11th Cir.), cert. denied, 479 U.S. 923
(1986); Rothery Storage & Van Co. v. Atlas Van Lines, Inc., 792 F.2d 210 (D.C. Cir.
1986), cert. denied, 479 U.S. 1033 (1987). These courts had found efficiencies through

integration as well as other procompetitive benefits resulting from an agreement or
collaboration among competitors that included restraints that are normally illegal per
se. For an excellent summary of these cases and others, see AMERICAN MED. ASS'N,
ANTITRuST LAW DEVELOPMENTS

http://lawecommons.luc.edu/annals/vol6/iss1/3
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Such arrangements may be evaluated under the rule of reason
when (1) the cooperating parties are generating substantial efficiencies that are passed on to customers in the form of lower
costs and/or better quality because they have integrated2 ' their
activities, and (2) it is necessary for the cooperating parties to
engage in the conduct that is ordinarily illegal to effect the integration that achieves the efficiencies.
The efficiencies must be substantial enough to outweigh the
potential adverse effect on competition of the cooperative activity-the more likely it is that a cooperative activity will have an
adverse effect on competition, the greater the showing of efficiencies must be. While the key to demonstrating efficiencies is
measuring the quantity of efficiencies that will be produced, it is
very difficult to measure the extent of efficiencies, especially if a
joint venture is being formed and is not yet in operation. Therefore, in the absence of measured efficiencies, the agencies will
look for characteristics in a joint venture that are likely to result
in the generation of efficiencies. Since efficiencies are generally
assumed to result from the integration of the cooperating parties, proving the extent of the efficiencies (and that cooperation
among the parties is necessary to achieve them) is often done by
proving the extent of integration involved.
Persons who sufficiently integrate their business activities are
considered to be a part of one business entity and are allowed to
engage in cooperative activities that are denied to independent
competitors. However, the antitrust laws distinguish between
different degrees of integration. It is more likely that efficiencies will be assumed to outweigh the anticompetitive effects of a
21. The concept of integration is a specific concept under antitrust laws. Under
the antitrust laws, integration occurs when two persons have joined and coordinated
their business activities for purposes of offering a product or service to purchasers in a
market. The most commonly recognized integration is where two parties may make a
common investment and share the opportunity for profit and the risk of loss. Maricopa, 457 U.S. at 356 (distinguishing a network engaged in illegal price fixing from a
legitimate joint venture by saying: "The foundations are not analogous to partnerships
or other joint arrangements in which persons who would otherwise be competitors
pool their capital and share the risks of loss as well as the opportunities for profit. In
such joint ventures, the partnership is regarded as a single firm competing with other
sellers in the market."). Courts also recognize "contract integrations," where the parties do not pool assets under common ownership but coordinate their activities in a
way that produces efficiencies. Rothery Storage, 792 F.2d at 214; see also ROBERT H.
BORK, THE ANTITRUST PARADOX: A POLICY AT WAR WITH ITSELF 264-79 (1978).
The assumption that a sufficient amount of integration produces efficiencies that outweigh the anticompetitive impact is, for the most part, correct-all of the great businesses in the world today resulted from persons integrating their activities.
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joint venture, and therefore be considered legal, as the amount
of integration of the participants increases. For example, the assumption that efficiencies will result is stronger when the parties
pool assets than it is when they only contractually integrate.
Networks can fall within this exception if they can prove that
they can achieve efficiencies, such as lower health care costs,
and better quality by integrating the activities of a number of
providers. In addition, they can prove that the agreements
among the network participants regarding fees or capitation
rates to be charged by the network are necessary to make the
network function. Upon falling within the exception, the agencies will analyze the network under the rule of reason.
C. The Antitrust Treatment of Different Levels of Integration
Among Physicians
Unintegratedgroups of physicians are those who wish to engage in a cooperative activity, but who do not want to pool economic resources, share any economic risk with other physicians,
or engage in a contract integration that generates substantial efficiencies. Physicians in unintegrated groups may not engage in
price fixing, group boycotts that are per se illegal, or divisions of
markets.
A group of independent physicians who do nothing more than
agree with each other to provide services pursuant to a discounted fee schedule is considered to be unintegrated. Such an
agreement can reduce transaction costs for payers who want a
network of physicians willing to discount fees, because the payer
need not approach and negotiate with each physician individually. These savings in transaction costs are efficiencies. However, the agencies do not believe that these efficiencies are
substantial enough to justify the potential adverse effects on
competition of the fee agreement among the physicians.22 The
agencies are concerned that the physicians will attempt to nego22. For example, the DOJ has said: "[A]n agreement among competitors to set a
minimum price, for example, would not be saved from per se condemnation simply
because the defendants claimed that the agreement eliminated the transaction costs
that consumers would otherwise incur in searching out the lowest price." U.S. Dep't
of Justice, Antitrust Div., Antitrust Enforcement Guidelines for International Operations (1988), reprinted in 4 Trade Reg. Rep. (CCH) 1 13,109.10, at 20,594 (Apr. 11,
1995) [hereinafter 1988 InternationalGuidelines]. The 1988 version of these guidelines was superseded by the Antitrust Enforcement Guidelinesfor InternationalOperations (1995), reprinted in 4 Trade Reg. Rep. (CCH) 1 13,107 (Apr. 11, 1995)
[hereinafter 1995 InternationalGuidelines], which does not address the issue of effi-

ciencies; the 1988 version is still an accurate view of the DOJ on this subject.
http://lawecommons.luc.edu/annals/vol6/iss1/3
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tiate fees that are higher than would prevail in free competition,
and then will back up those negotiations with a threat of boycott. Therefore, these arrangements among unintegrated physicians are per se illegal and do not qualify for rule of reason
analysis.
Partially integrated groups of physicians are those who are

willing to pool some economic resources and share some economic risk with other physicians, but do not want to merge their
practices with other physicians. If the physicians have sufficiently integrated their activities and are generating substantial
efficiencies, physicians in partially integrated groups may, under
some circumstances, agree on prices that they will charge to
third parties, refuse to deal with some parties, and agree on
which patients each will treat. These arrangements will not be
per se illegal and will be reviewed under the rule of reason. Partially integrated groups of physicians that are generating substantial efficiencies are sometimes called "legitimate joint
ventures." Independent practice associations and preferred provider networks, depending on their activities, may be legitimate
joint ventures.
Fully integrated groups of physicians are those who have

merged their practices into one entity, such as a partnership or
medical corporation. Fully integrated groups are not considered
a joint venture network because the physicians are not competing with each other in independent practice. Because they have
fully integrated, it is assumed that the group is generating substantial efficiencies. Physicians in fully integrated groups may
decide upon the prices that they are going to charge to payers,
they may refuse to deal with payers who do not accept their
terms, and they may decide which physicians in the group will
treat which patients. 23 Physicians who are employed by a corporation, such as a hospital, foundation, HMO, insurer, or other
entity, are also considered to be part of a fully integrated group.
Multiprovider networks, such as combinations of hospitals and
23. However, there are limits to how large a fully integrated group may grow by
acquiring the practices of competing physicians. The group may not acquire a monopoly or cause a substantial increase in the concentration of ownership of physician
services by merging with other physicians with practices in the market. For guidelines
on how large a firm can grow by merging with other firms, see U.S. Dep't of Justice &
Fed. Trade Comm'n, Horizontal Merger Guidelines, reprinted in 4 Trade Reg. Rep.

(CCH) ! 13,104 (Apr. 2, 1992) (amended Apr. 8, 1997). A physician group may grow
by bringing in additional physicians from outside of the market.
Published by LAW eCommons, 1997
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physicians, may also be fully integrated if they are all merged
into a single entity or are under common control.
D. Proving Sufficient Integration and Efficiencies to Qualify
for Rule of Reason Analysis
In summary, the application of the antitrust laws to
unintegrated and fully integrated groups of physicians is very
clear. The problem for physicians and their attorneys is knowing when a partially integrated group, such as a network, will be
deemed to have sufficient integration to generate efficiencies
substantial enough to fall within the exception to the per se
rules.
There is general consensus among learned commentators that
federal case law does not provide sufficient guidance for joint
ventures.24 No cases have defined with precision the quantity of
efficiencies that are necessary nor the extent of integration between the parties that will be deemed sufficient to meet the burden of showing the existence of substantial efficiencies. Instead,
the courts rely on the use of a process to evaluate whether the
efficiencies made possible by the restraints involved in the joint
venture enhance competition more than they harm competition.
This is a flexible process-it does not place arbitrary thresholds
on the amount of efficiencies or integration that must be present
nor does it define a maximum amount of efficiencies beyond
which a partially integrated joint venture is clearly legal. Instead, the amount of integration and efficiencies are evaluated
together with all other relevant characteristics of the joint venture that might affect competition, such as the market power of
the venture, together with the nature of competition in the
market.
The nature of this process has become confusing because of
controversy over how it should be articulated. It is apparent, as
a practical reality, that the process must have at least two steps.
First, the court must decide whether the restraint involved in the
24.

Most critics agree that antitrust case law fails to provide clear guidance for

attorneys and businesses as to what is permissible under the law. See, e.g., Thomas A.
Piraino, Jr., Reconciling Competition and Cooperation:A New Antitrust Standardfor
Joint Ventures, 35 WM. & MARY L. REv. 871, 878 (1994); Thomas A. Piraino, Jr.,
Beyond Per Se, Rule of Reason or Merger Analysis:A New Antitrust Standardfor Joint
Ventures, 76 MiNN. L. REv. 1, 12 (1991); Robert Pitofsky, A Frameworkfor Antitrust

Analysis of Joint Ventures, 74 GEO. L. J. 1065 (1986) (Mr. Pitofsky is currently the
FTC Chairman); James T. Halverson, The Futureof HorizontalRestraintsAnalysis, 57
ANTITRUST L.J. 33 (1988).
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joint venture that would ordinarily be deemed per se illegal
should be evaluated under the rule of reason, using the test articulated above. Second, if the court does not declare the joint
venture illegal per se, it must apply the rule of reason and evaluate the extent of measurable efficiencies or integration involved.
As a practical matter, the two steps tend to run together. Determining whether to evaluate a restraint that is normally illegal
per se under the rule of reason requires some inquiry into
whether the rationale for the exception from per se treatment is
present, in other words, whether the restraint enables the joint
venture to generate efficiencies. This inquiry resembles the rule
of reason analysis itself.
This practical reality worries antitrust law enforcement officials and supporters of strict enforcement of the antitrust laws
because it appears to eliminate rules of per se illegality. The
premise of these rules is that certain trade restraints are so inherently anticompetitive that there is no need to inquire into
their effect on competition. Once these restraints are examined
to consider their overall effects on competition, then the premise of per se illegality is lost. Antitrust enforcement officials
want to preserve the strength of the per se rule as much as possible. Other commentators want the antitrust laws to be flexible
enough to accommodate legitimate joint ventures, as they have
brought and are likely to continue to bring many benefits to
consumers. 25 The result has been controversy over how to structure the inquiry to determine if the exception to per se illegality
for legitimate joint ventures should apply.
Some commentators feel that federal courts have addressed
this problem by creating an intermediate standard between the
per se rule and the rule of reason, known as the "quick look"
rule of reason test.26 They claim that this test is for restraints
that have the characteristics of per se illegal offenses, but which
are not clearly without justification due to extenuating circumstances. As a result, the restraints are not summarily condemned under the test as being per se illegal; instead the court
takes a "quick look" at the activity to see if the restraint is justified. The quick look may reveal that the practice is not justified,
25.

BORK, supra note 21; Clark C. Havighurst, Are the Antitrust Agencies Over-

regulatingPhysician Networks? 8 LoY. CONSUMER L. REP. 78 (1995-96); Letter from
Clark C. Havighurst to Henry J. Hyde, Chairman, House Comm. on the Judiciary
(Mar. 8, 1996) (on file with the author).
26. See, e.g., WILLIAM C. HOLMES, ANTrRUST LAw HANDBOOK 227-28, 272-87
(1997).
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in which case it is declared illegal. 27 The quick look might also
reveal that the practice is clearly procompetitive, in which case it
could be found legal. However, what is not clear is what happens if a quick look is taken and it is not clear whether the restraint is justified, thereby requiring a full-blown rule of reason
analysis. The quick look "test" then becomes a screen to determine whether a restraint that is normally per se illegal is clearly
justified or whether a full review of the restraint needs to be
made to determine its legality. Such a clearly defined procedure
has not been set forth by federal courts. It is not yet clear
whether the quick look test actually exists and, if it does,
whether it is really only a screen.
As a result of this controversy, both the DOJ and the FTC
have changed their general approaches for evaluating the legality of joint ventures in recent years. Initially, the agencies set
forth a procedure to screen restraints that are normally per se
illegal from those that should be evaluated under the rule of
reason. Subsequently, they both retreated from that approach,
apparently to strengthen the concept of per se illegality. Thus,
in 1988, the DOJ stated 28 that it would review joint ventures
under a rule of reason analysis because the agency felt that joint
ventures "typically achieve integrative efficiencies. ' 29 A joint
venture was defined as "any collaborative effort among firms,
short of a merger, with respect to [research and development],
production, distribution, and/or the marketing of products or
services. 3 ° In the same statement, the DOJ described the steps
in the rule of reason process.3 '
27. The Supreme Court may have used such a quick look test to find a group
boycott to be illegal in Federal Trade Comm'n v. Indiana Fed'n of Dentists, 476 U.S.

447 (1986). In that case an association of dentists boycotted a requirement by a
health plan that dentists submit x-rays together with claims for payments to substantiate the necessity of the procedures performed. The Supreme Court did not find the
boycott illegal per se; instead, it evaluated the boycott under the rule of reason, but
found the boycott to be illegal without a full-blown rule of reason analysis. The Court
felt that the restraint could be condemned without such a procedure.
28. 1988 International Guidelines,supra note 22.
29.

Id. at 1 13,109.10, § 3.4.

30. Id.
31. First, the DOJ looked for any anticompetitive effect(s) in the joint venture
market. Second, it looked for any anticompetitive effect(s) in any "spillover markets." Next, it looked at the likely competitive effects of any nonprice vertical restraints as a result of the joint venture. If after reviewing the joint venture under
these three steps, the DOJ concluded that the joint venture did not have any likely
anticompetitive effects, it would not challenge it. If, however, the joint venture had
significant anticompetitive effects, the DOJ would determine whether the procompehttp://lawecommons.luc.edu/annals/vol6/iss1/3
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The DOJ withdrew this statement in 1995.32 The current DOJ

approach was articulated by Acting Assistant Attorney General
Joel Klein in a speech about the analysis of horizontal restraints
(joint ventures between competitors involve such restraints).33
According to Mr. Klein, the DOJ will first determine whether
the agreement is the type of restraint that is currently recognized by the courts as being a per se violation. If the agreement
is not, then the Antitrust Division will look at any procompetitive justifications for the restraint. This statement is confusing
since it does not clarify whether a restraint that is normally per
se illegal will be evaluated under the rule of reason if it is a
necessary part of the operations of a legitimate joint venture.
Obviously it will, since the Supreme Court has recognized that
the rule of reason will be used to evaluate such restraints a4 The
DOJ is simply protecting the status of per se rules by refraining
from clarifying when the restraints involved may be reviewed
under the rule of reason.
Mr. Klein stated that the parties to the agreement will have
the burden of producing either factual or expert (or even both)
evidence of procompetitive justifications. If the proffered justifications are unsubstantiated, then the agreement will be declared illegal. If the Division finds significant procompetitive
benefits, then the Division will determine whether the agreement's likely anticompetitive effects outweigh its procompetitive
benefits. Mr. Klein noted that this type of analysis usually requires an elaborate market analysis unless there is convincing
evidence of direct market effect on price or output. Finally, Mr.
Klein pointed out that there is a need to show real procompetitive benefits only if there are actual anticompetitive effects.
The FTC's change in its analysis of joint ventures may also
have been an attempt to protect the per se rules. In its 1988
titive efficiencies attempted by the joint venture outweighed its anticompetitive effects. Id at § 3.41.
32. When the DOJ withdrew this statement, it updated the International Guidelines. 1995 InternationalGuidelines,supra note 22. The update is silent with regard to
the DOJ's analysis of joint ventures.
33. Joel Klein, Acting Assistant Attorney Gen. for Antitrust, U.S. Dep't of Justice, A Stepwise Approach to Antitrust Review of Horizontal Agreements 6, Address
Before the American Bar Ass'n Antitrust Section Semi-Annual Fall Policy Program
(Nov. 7, 1996).
34. See supra note 20.
35. Klein, supra note 33, at 7-8.
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opinion in Massachusetts Board of Registration in Optometry,36
the FTC reviewed Supreme Court decisions and noted that
there is no bright line between the per se and rule of reason
analyses. It pointed out that the real inquiry is the same under
both tests: "[W]hether or not the challenged restraint enhances
competition. ' 37 Ignoring any distinction between the tests, the
FTC established a "structure" or "decision tree" for horizontal
restraint analysis.
Under the Massachusetts Board structure, the FTC would first
ask whether the restraint was inherently suspect, meaning obviously anticompetitive. If so, then the FTC would declare it illegal without further factual inquiry. If the restraint was not
inherently suspect, then the FTC would employ the traditional
rule of reason analysis. If, however, the restraint was inherently
suspect, the FTC would look for a plausible efficiency justification for the practice. If the justification was not plausible, then
the practice would be condemned. If plausible, the FTC would
see if the justification was truly valid. Once the Commission
found the justification valid, the restraint would be examined
under the rule of reason. If, however, the justification is found
to be invalid, then the restraint is declared unlawful without further inquiry.38

The FTC may have modified this "decision tree" in California
Dental Association,39 where it said that the Supreme Court had
not abandoned the traditional analysis of horizontal restraints,
meaning the use of per se rules and rule of reason analyses. The
FTC acknowledged the distinction between the per se and rule
of reason analyses and the importance of utilizing one of the
tests.4 ° Consequently, the FTC used the traditional per se rule
to find a restraint illegal. However, regardless of the terminology used, the description of the process in Massachusetts Board
of Optometry may be a good summary of how the FTC analyzes
joint ventures if the '4words
"per se illegal" are substituted for
"inherently suspect." 1
36.

[1983-1987 FTC Complaints and Orders Transfer Binder] Trade Reg. Rep.

(CCH) 22,269, at 23,111 (Complaint, Dkt. 9195, July 8, 1985).
37. Id.
38. Id.
39. California Dental Ass'n, 5 Trade Reg. Rep. (CCH)
1996).

24,007, at 23,778 (Apr. 4,

40. Id. at 23,787.
41. The FTC has a task force evaluating joint venture analysis. It is expected that
it will issue a report in 1997, further explaining the FTC's approach to joint ventures.
See FTC Notice, Comment and Hearings on Joint Venture Project, 62 Fed. Reg. 2295
http://lawecommons.luc.edu/annals/vol6/iss1/3
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A way to conceptualize how the agencies and the courts review a network that uses restraints normally considered to be
illegal per se, such as an agreement among the participating physicians about fees, is the following three-step analysis. First,
they will consider whether the joint venture and its restraints are
obviously anticompetitive. For example, they will review the
network to see if it is obviously meant to gain market power
over payers and fix fees at levels higher than would prevail if the
physicians competed with each other for the business of payers.
If the network is not obviously intended to restrain competition,
the agencies will consider whether the network generates more
than a minimal amount of efficiencies, considering, for example,
whether the network generates only transactional efficiencies or
a greater amount of efficiencies. Finally, they will consider
whether the restraints involved are obviously needed to generate the claimed efficiencies.
If the network is not obviously anticompetitive and the network can plausibly claim that the restraints are necessary to generate substantial efficiencies, then the network will be more
thoroughly reviewed pursuant to a rule of reason analysis to
evaluate (1) whether the efficiencies are sufficient to outweigh
the anticompetitive effects of the restraints, and (2) whether the
restraints are truly necessary to generate the efficiencies. The
greater the anticompetitive effect of the restraint, the greater
the degree of efficiencies that must be shown to justify them.
As discussed above, the quantity of efficiencies is key to this
analysis. However, there is controversy over what quantity of
plausible efficiencies must be shown by a joint venture to qualify
for rule of reason treatment, and what quantity must actually be
shown to pass a rule of reason inquiry. Since the degree of integration among the participants in a joint venture is used as a
way to estimate the extent of efficiencies, the controversy is
often over the extent of integration necessary to qualify for and
then pass a rule of reason analysis. The agencies call for a relatively strong showing of efficiencies or integration before a joint
venture can qualify for a rule of reason analysis. However, one
learned commentator, Professor Havighurst, 42 and at least one

federal appellate court 43 would require a lower threshold.

(1997). Testimony of the hearings held by the Project are available on the FTC's
website. See supra note 1.

42. Havighurst comment, supra note 25.
43.

Rothery Storage, 792 F.2d 210.
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The argument for the lower threshold is that setting a high
threshold puts the agencies and the courts in the position of regulating the merits of the products offered by joint ventures by
deciding which products are good enough to allow in the market. Professor Havighurst argues that the agencies should do no
more than decide whether the joint venture has a material adverse effect on competition pursuant to a rule of reason analysis,
and should not be in the business of deciding the merits of the
products offered by joint ventures. This, he argues, is for the
market to decide. 44 The counterargument, for higher thresholds,
is that low thresholds would weaken the per se rule by allowing
a wide range of cooperative activity that is normally per se illegal to be evaluated under the rule of reason. At the time of this
publication, the agencies continued to adhere to a high threshold in order to protect the per se rules.
E. The Rule of Reason Analysis-The Importance of
Market Power
As a practical matter, since the degree of integration is a way
to estimate efficiencies, showing sufficient integration to qualify
for rule of reason analysis is often enough to pass the analysis
itself. Once sufficient integration is shown, the key issue in a
rule of reason analysis is determining whether the joint venture
has market power.
When a network qualifies for rule of reason analysis, a structured review of the impact of the network on competition takes
place. If a joint venture is proposed, then the agencies are concerned about the likely effect that the joint venture will have on
competition in the market. If the joint venture is operating,
then the agencies are concerned about the impact that the joint
venture is actually having on competition in the market and the
impact that it is likely to have in the future. There are substantial differences in the types of evidence available to evaluate
proposed joint ventures as opposed to operating joint ventures,
but the same structured review process is applied to both.
First, the product and geographic markets at issue must be
defined. Then, the effect of the network on competition in the
market is evaluated. With regard to a proposed joint venture,
the agencies rely on the degree of market power that the joint
44.

Havighurst comment, supra note 25.
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venture will have as a reliable predictor of whether it will harm
competition.
Market power is the ability of a competitor in a market to
restrict output and raise prices above competitive levels. Generally only competitors with very large market shares have the
power to force purchasers to accept higher than competitive
prices. For example, a network that was large enough could
agree to fix fees and to boycott purchasers who refuse to accept
those fees. It is assumed that a partially integrated joint venture, such as a network, that can generate substantial efficiencies
will do so in a competitive market where it does not have market power. It is also assumed that a joint venture that has too
much market power will create an anticompetitive environment,
thereby negating the benefits that consumers would reap from
the efficiencies that the network can generate.
Case law fails to provide firm guidance about the permissible
size of a joint venture, including a network. Generally, a single
firm that constitutes less than thirty percent of the market does
not have market power.45 The agencies usually evaluate the
market power of joint ventures under their 1992 Horizontal
Merger Guidelines.4 These guidelines are concerned not only
with the market power of a single firm, but the relationship of
the market power of a firm with the market power of all other
firms in the market. The concern is that a small number of firms
that together have a great deal of market power might conspire
to restrict output and raise prices. The agencies apply a formula
to determine whether a merger will result in an impermissible
increase in the percentage of the market. Mergers that would
create a firm with a market share of less than thirty percent
could transgress these guidelines if the market is already highly
concentrated.47
The focus of market power analysis in physician and multiprovider networks tends to be on the market power of the providers
combining to form the network. The issue is whether the physi45. ANTITRUST LAW DEVELOPMENTS, supra note 20, at 59-62.
46. U.S. Dep't of Justice & Fed. Trade Comm'n, Horizontal Merger Guidelines
(1992), reprinted in 4 Trade Reg. Rep. (CCH) 13,104 (Apr. 2, 1992).
47. There is also a developing economic theory showing that combinations of
small percentages of participants in a market result in price increases and therefore
could be anticompetitive. This school of thought applies econometric analysis to predict the impact on prices of mergers or joint ventures. For a simple description of
these theories, see Robert H. Lande & James Langenfeld, The Evolution of Federal

Merger Policy, 11
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cians and providers in the network could conspire to exercise
market power to prevent managed care from entering the market or to raise prices above competitive levels. The agencies will
review a number of factors to make this evaluation, including
the percentage of physicians in the market, whether the network
is exclusive 4 or nonexclusive, 49 whether there are other networks in the market, the extent of managed care penetration of
the market, and the dependence of providers on managed care
plans for revenues.
Market power is also an important factor when the agencies
review a joint venture that is in operation. However, the actual
effect of the joint venture on competition is more important. To
judge the effect, the agencies will look at pricing levels, purchaser perceptions about their alternatives to the joint venture
for supplies of the product involved, actual purchasing patterns,
and other evidence. If this evidence tends to show that the market is not competitive, the existence of market power on the
part of the joint venture may cause the agencies to conclude that
the joint venture is the cause of the anticompetitive effects.
After reviewing the likely or actual effects of the joint venture
on competition, the agencies will consider whether any efficiencies produced by the joint venture outweigh the harm to competition. Then the agencies will consider whether the agreements
among the joint venture participants that are normally per se
illegal, such as a fee agreement among the physician participants
in a network, are necessary to achieve the efficiencies generated
by the joint venture.
II.

ANALYZING NETWORKS UNDER THE STATEMENTS

The purpose of the Statements is to provide guidance to physicians and their attorneys about how networks will be evaluated
and the positions of the agencies regarding joint ventures in general. The key information is found in Statement Eight, which is
entitled "Physician Joint Venture Networks," and Statement
Nine, which is entitled "Multiprovider Networks." These Statements apply to health care delivery networks owned by hospitals
48. An exclusive network is one where the physicians do not contract with other
networks or health plans apart from the network. STATEMENTS, supra note 1, at 64.
See infra section III(C).
49. In a nonexclusive network, the physicians remain free to contract with other
networks or with health plans that do not contract with the network. Id. See infra
section III(C).
http://lawecommons.luc.edu/annals/vol6/iss1/3
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and/or other providers, including physicians. Both Statements
apply essentially the same principles.
The general approach used by the agencies to evaluate joint
ventures provides the framework for the guidelines in Statements Eight and Nine. To summarize the discussion above, the
agencies evaluate a network to see if it is inherently suspect-if
it involves a price-fixing arrangement or other kind of conspiracy to restrain trade that is per se illegal with no redeeming features. If the network has plausible efficiencies, 50 especially as
evidenced by sufficient integration, then it qualifies for rule of
reason analysis. A high threshold is set to determine plausible
efficiencies-transactional efficiencies are not sufficient to qualify a joint venture for rule of reason analysis. Then the agencies
will determine if the efficiencies, especially as evidenced by the
degree of integration, are substantial enough to outweigh any
adverse competitive effects. The market power of the network
will be evaluated to determine the likely anticompetitive effect
of the network. The greater the potential anticompetitive effects, the greater the efficiencies must be, especially as evidenced by greater degrees of integration, to justify these
anticompetitive effects.
However, the Statements provide more than a general framework. They provide guidance about the degree of integration
necessary to qualify for rule of reason analysis as well as the
extent of integration needed and degree of market power allowed to pass a rule of reason analysis. They begin by defining
the characteristics of a network that will be considered sufficiently integrated with a degree of market power to qualify for
and pass the rule of reason analysis. For these networks, the
agencies created an antitrust safety zone.
For a network to be in the safety zone, its members must
share substantial financial risk, which the agencies regard as a
form of financial integration, and the physicians may not account for more than twenty percent of any specialty in the mar50. The agencies recently amended their Horizontal Merger Guidelines to include
a revised section on efficiencies. This section is designed to provide guidance about
how the achievement of efficiencies through a merger between two firms will affect
the agencies' analysis of the legality of the merger. It is similar to the agencies' analysis of efficiencies in a joint venture, and is probably the most current view of how they
approach the effect of efficiencies on a joint venture as well as for mergers. Horizontal Merger Guidelines, supra note 46, at 20,573-11 n.46. Another good description is
found in the DOJ's 1988 InternationalGuidelines, supra note 22, at 20,594.
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ket if the network is exclusive, 5 and no more than thirty percent
of the market if nonexclusive. Substantial financial risk is created through arrangements whereby the venture assumes capitation,52 receives a percentage of premium, 3 uses global fees,54 or
uses significant financial incentives to achieve specified cost containment goals, including substantial fee withholds55 as well as
penalties or rewards based on whether the network meets cost
or utilization goals.
The agencies consider the assumption of financial risk to be a
form of financial integration because they believe that it gives
the network an incentive that assures that the network will engage in activities that give rise to efficiencies, such as better
quality and/or lower costs. Those activities are not specified by
the agencies, but are generally recognized in the industry to include physician credentialing to assure that their training is adequate, utilization review to prevent the provision of unnecessary
care, physician profiles to teach physicians how to improve their
quality and cost effectiveness, gatekeepers to control referrals,
practice guidelines 56 for use by physicians in the network, and
total quality improvement to consistently attain a desired medi51. STATEMENTS, supra note 1, at 64.
52. A "capitated" rate is a fixed, predetermined payment per covered life
(the "capitation")
a health
plan to the joint venture in exchange for the
joint
venture's (notfrom
merely
an individual
physician's) providing and guaranteeing
provision
of a defined
set ofofthe
coveredservices
to covered
for
a specified
period,
regardless
amount of services
actuallyindividuals
provided.
Id. at 68 n.30.
53. In this arrangement, the network agrees to provide designated services to plan
beneficiaries in return for a predetermined percentage of premium or revenue from
the plan. Id. at 68.
54. Global fees involve an "agreement by the venture to provide a complex or
extended course of treatment that requires the substantial coordination of care by
physicians in different specialties offering a complementary mix of services, for a
fixed, predetermined payment, where the costs of that course of treatment for any
individual patient can vary greatly due to the individual patient's condition, the
choice, complexity, or length of treatment, or other factors." Id. at 69.
55. Fee-withhold arrangements involve "withholding from all physician participants in the network a substantial amount of the compensation due to them, with
distribution of that amount to the physician participants based on group performance
in meeting the cost-containment goals of the network as a whole." Id. at 69.
56. Practice guidelines are summaries of how to treat patients with a given illness
or injury with the goal of achieving the best possible outcome most efficiently. Not all
practice guidelines have this objective. Some are designed for other purposes, and
some do not make an effort to identify the most efficient ways to care for patients
with a given problem. KIRK B. JOHNSON, ET AL., AMERICAN MED. Ass'N, LEGAL
IMPLICATIONS OF PRACTICE PARAMETERS

2-6 (1990). A network wishing to use prac-

tice guidelines to qualify for rule of reason treatment should design them to achieve
efficiencies.
http://lawecommons.luc.edu/annals/vol6/iss1/3
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cal outcome at the lowest possible cost.57 The agencies are willing to assume that if a network is engaged in substantial risk
sharing, it must be using these techniques and generating actual
efficiencies, such as reduced cost and higher quality.
The agencies also describe the characteristics of networks that
will qualify for a rule of reason analysis, but do not fall within a
safety zone. These networks will not be deemed illegal per se,
but will be reviewed under the rule of reason to determine if
they are legal. TWo types of networks are considered to qualify
for the rule of reason analysis.
One type is a network that exceeds the safety zone specialty
concentration limits, but is comprised of physicians who share
substantial financial risk. Because the physicians in such a network have assumed substantial financial risk, the network has a
plausible argument that it is demonstrating efficiencies. However, because the network's specialty concentration exceeds the
safety zone limits, it will have to prove that those efficiencies
will outweigh any anticompetitive effects that it may have due to
its market power. While the Statements indicate that a network
may be comprised of a greater percentage of specialists than the
safety zone percentage limits permit,5 8 they fail to identify what
percentage will be permissible.
The other type of network is one not engaged in substantial
risk sharing but that uses techniques to reduce costs and enhance quality that are used by risk-assuming networks (referred
to as "clinical integration" 59). For example, a network in a competitive market may want to market itself to payers who prefer
to deal on a fee-for-service basis, such as preferred provider organizations and self-insured employers, and may want to get a
competitive edge by using techniques to lower cost and improve
quality. Statement Eight recognizes that if a network uses some
or all of these techniques, it has a plausible argument that it is
generating efficiencies and therefore qualifies for a rule of rea57. Total quality improvement ("TQI") is a set of techniques designed to reduce
variation in output around a mean, with the mean being a desired outcome for the
process. It was created for industrial processes, and efforts are being made to apply
the concepts to health care. For a description of TQI in the industrial context, see
KAORU ISHIKAWA, GUIDE TO QUALITY CONTROL (2d ed. 1986). For an application
to health care, see Avedis Donabedian, The Quality of Care: How Can It Be As-

sessed?, 260 JAMA 1743 (1988);
HEALTH CARE DELIVERY
LIVERY (1996).

58.
59.

(1989);

BRENT JAMES, QUALITY

MANAGEMENT FOR

PETER BOLAND, REDESIGNING HEALTH CARE DE-

supra note 1, at 63, 77-79.
See supra note 10 regarding the use of this term.
STATEMENTS,
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son analysis. The agencies will evaluate it to determine if the
efficiencies generated by the techniques outweigh any adverse
effect on competition. The Statements consider a network to be
"clinically integrated" if it is
implementing an active and ongoing program to evaluate and
modify practice patterns by the network's physician participants and create a high degree of interdependence and cooperation among the physicians to control costs and ensure
quality. This program may include: (1) establishing mechanisms to monitor and control utilization of health care services
that are designed to control costs and assure quality of care;
(2) selectively choosing network physicians who are likely to
further these efficiency objectives; and (3) the significant investment of capital, both monetary and human, in the necessary infrastructure and capability to realize the claimed
efficiencies.6"

While this is an example of clinical integration, it is by no
means an exclusive definition. In addition, other types of integration may exist, enabling the network to prove the existence
of efficiencies in other ways. 6 '
Statements Eight and Nine set forth the rule of reason analysis that the agencies will apply to qualifying networks. The fourstep analysis takes into account the characteristics of the network and the competitive environment in which it operates.
(1) Define the Productand Geographic Market Little guidance
is provided about how the market will be defined. Instead,
the Statements incorporate by reference the 1992 Horizontal Merger Guidelines,62 which set forth substitutability as
the basic test. In other words, a product market consists of
services that consumers are willing to substitute for each
other, and a geographic market consists of those sellers
from whom consumers in a locality are willing to purchase.
In both cases, a key test for substitutability is from whom
purchasers would buy if the seller from whom they are ac60. STATEMENTS, supra note 1, at 72-73.
61. However, it is likely that a more substantial proof will be required to demonstrate the likelihood of such efficiencies. It will not be enough to show the integration; it will also be necessary to prove why the integration is likely to produce
efficiencies since the likelihood of efficiencies will not be presumed. See 1988 International Guidelines, supra note 22, at 20,602 (in a rule of reason analysis, "[t]he parties
bear the burden of proving such offsetting procompetitive efficiencies on the basis of
clear and convincing evidence. The burden increases in direct proportion to the magnitude of the likely anticompetitive harm.").
62. Horizontal Merger Guidelines, supra note 46.
http://lawecommons.luc.edu/annals/vol6/iss1/3
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customed to buying increased its prices slightly but
significantly.
(2) Evaluate the Competitive Effects of the Network: After defining the market, the agencies will evaluate whether the
network could (a) raise prices above competitive levels, or
(b) prevent or impede the formation of other networks or
health plans. This primarily involves an assessment of market power. The agencies will also consider whether the network has taken steps to prevent spillover effects by
minimizing the exchange of competitively sensitive information among the participants; they will also consider the intent of the network.
(3) Balance the Procompetitive Efficiencies: After evaluating
competitive effects, the agencies will balance the efficiencies
that will be generated by the network against any anticompetitive effects of the network to determine if the network
is, on balance, procompetitive. The parties must also be
able to show that the efficiencies cannot be achieved in a
less anticompetitive fashion than by the formation of the
network.
(4) Evaluate Collateral Agreements: The agencies will determine if there are anticompetitive agreements among physicians in the network that are not necessary to achieve the
efficiencies. (If there are, the problem can be resolved by
eliminating the agreements.)
The Statements list the following factors that indicate that a
network is anticompetitive and likely to fail a rule of reason
63
analysis:
(1) statements evidencing an anticompetitive purpose;
(2) a recent record of anticompetitive behavior or collusion by
the network in the market, including attempts to impede or
obstruct managed care development;
(3) an obvious anticompetitive structure, such as an exclusive
network with a very high percentage of local area physicians
that fails to demonstrate any plausible efficiency
justification;
(4) the absence of network mechanisms to generate significant
efficiencies or otherwise increase competition;
(5) the existence of anticompetitive collateral agreements, such
as agreements among the physicians to fix prices for those
not dealing through the network; and
63.

STATEmEmrs,

supra note 1, at 74; see also Hypothetical Three, id. at 89.
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(6) the absence of a means to prevent anticompetitive spillover
effects.
The extent of the rule of reason analysis will vary depending
on how difficult it is to decide if the venture is procompetitive or
anticompetitive. The agencies can quickly conclude that the
network is legal if (1) the network is one where the members
share substantial financial risk or the market has a substantial
amount of clinical integration, (2) the network has a small percentage of any specialty in the market, and (3) the market in
which it operates is competitive. On the other hand, if a network obviously has many of the six characteristics listed above,
then the agencies can quickly conclude that the network is illegal. A more in-depth, and therefore time-consuming and expensive, analysis may be needed for networks that fall between
these obvious examples.
Finally, the Statements also describe a way that a physician
network can be legal without sharing substantial financial risk or
being clinically integrated. This type of network is designed to
allow a group of physicians who want to market themselves as a
group to arrive at price arrangements with a payer without
agreeing on fees among themselves or agreeing in other manners that are per se illegal. Statement Nine explains this type of
model, which is described more fully below.
III. APPLICATION OF THE STATEMENTS
A. A Simple Network-The Messenger Model
As stated above, many physicians feel that the Statements
make network organization such a large undertaking that it is
impractical. The basis for this belief is that the network has to
be able to assume substantial financial risk, and therefore be
able to manage risk, or have adequate clinical integration in order to fall within a safety zone or qualify for rule of reason analysis. The conventional wisdom is that such a network requires a
multimillion dollar investment, employment of skilled managers, and sophistication among the physicians in managing risk.
This belief leaves physicians feeling powerless. Physicians just
starting out in network organization often do not feel ready for
risk sharing or clinical integration, and they feel incapable of
raising millions of dollars. As a result, they are vulnerable to
canards that distract them from adapting to managed care. For
example, some physicians believe that joining a union empowered to engage in collective bargaining on their behalf would be
http://lawecommons.luc.edu/annals/vol6/iss1/3
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a better solution. Although that option is currently illegal for
physicians in independent practice, 64 it continues to draw
interest.65
What physicians just entering the world of managed care usually want to do is collectively market their services, which they
wish to provide on a fee-for-service basis66 (hereinafter referred
to as a simple network). In other words, the efficiencies that
they want to offer the market are transactional efficiencies only.
In addition, they may want to include large numbers of physicians in the network to avoid tension within the medical community, which tension can result when providers are not
included in a network. These physicians need to start with a
simple network, adding features such as risk sharing and clinical
integration as they gain experience.
There is often a market for simple networks. It is composed
of payers who want discounted fees and unrestricted access to
large numbers of providers. These payers want to handle utilization review functions themselves or they do not want features
of managed care such as utilization review or gatekeepers. Payers with these needs are usually self-funded employers, businesses that provide administrative services to self-funded
payers, such as third-party administrators, preferred provider
organizations ("PPO"), or brokers that offer PPO networks to
self-funded employers or third-party administrators. If physi64.

Under the labor exemption to the antitrust laws (section 20 of the Clayton

Act, 15 U.S.C. § 17 (1994)), employed physicians can unionize but are limited to col-

lective bargaining with their employer, which is often other physicians. According to
a survey by the American Medical Association, only 8.1% of nonfederally employed
physicians work for health maintenance organizations. Of the rest of nonfederally
employed physicians, 30.7% work for group practices or free-standing centers; 18.7%
work for medical schools, universities, or colleges; 23.2% are employed by state, local,
or other governments; and 16.7% work for private hospitals. CENTER FOR HEALTH
POL'Y RES., AM. MED. Ass'N, PHYSICIAN MARKETPLACE STATISTICS 174 (Martin L.
Gonzalez ed., 1997). Self-employed physicians in independent practice are considered independent contractors and do not qualify for the labor exemption from the
antitrust laws or the protection of the National Labor Relations Act, 29 U.S.C.
§ 152(3) (1994) ("The term 'employee' ... shall not include.., any person having the
status of an independent contractor .... ").
65. The agreement of podiatrists to join the Office and Professional Employees
International Union, which was announced at about the same time as the issuance of
the Statements, drew as much attention and inquiry from physicians as did the Statements. See Steven Greenhouse, Podiatriststo Form Nationwide Union: A Reply to
HMOs, NEW YORK TIMES, Oct. 25, 1996, at A6.
66. In contrast, networks that are paid on a "risk" basis accept capitation, percentage of premium, fee withholds, or other arrangements that put the network at financial risk for the use of health care services by beneficiaries of the health plan.
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cians organize such a network and agree on fees to charge payers who contract with the network, or if they authorize one
person to negotiate fees with payers on behalf of the physicians
in the network, they have engaged in price fixing that is illegal
per se under federal antitrust laws.67
However, Statement Nine describes a way to organize a simple network that is legal. It involves the use of the messenger
model. This model allows a simple network to arrive at fee arrangements with payers and to dialogue with payers about nonfee-related issues, such as the medical policy of the health plan
and the administrative procedures for hospital admission
preauthorization.
1. How the Messenger Model Works
The object of the messenger model is to allow a simple network to operate without the existence of a fee agreement among
the participating physicians. This means that the network physicians cannot communicate with each other to agree on a fee
schedule. Further, even in the absence of such an agreement,
the physicians cannot agree to abide by a fee schedule negotiated on their behalf by an agent of the network. The messenger
model allows the physicians to appoint a "messenger" who facilitates the development of a fee schedule between payers and
each physician in the network. The process works as follows.
The messenger communicates with each physician individually about what fee range the physician is willing to accept. The
communications may be handled by telephone, mail, or personal
meetings. The messenger may not inform any physician about
the fee ranges that are acceptable to other physicians in the network, and the physicians may not communicate among themselves about fees that are acceptable to them.
Each physician may give the messenger authority to accept
contracts from payers that are within the limits of the fee range
that the physician is willing to accept. 6 One of the variations on
67. Arizona v. Maricopa County Med. Soc'y, 457 U.S. 332 (1982).
68. The 1993 Statements did not expressly authorize the use of the messenger
model. The 1994 Statements authorized the use of the messenger model, but did not
expressly authorize physicians to preauthorize the messenger to accept offers from
payers. As a result, all offers made by payers had to be communicated to physicians
individually, and each physician had to make a unilateral decision about whether to
accept an offer. 1994 STATEMENTS, supra note 3, at 94-96. This made messenger
models cumbersome, time consuming, and expensive to operate. Jack R. Bierig, Physician-SponsoredManaged Care Networks: Two Suggestions for Antitrust Reform, 6
http://lawecommons.luc.edu/annals/vol6/iss1/3
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this authority is that the physician may authorize the messenger
to accept contracts with fees equal to or better than fees provided in a contract already accepted by the physician.
The messenger may aggregate the information obtained from
each individual physician. In doing so, the messenger may develop a schedule showing what percentage of physicians in the
network would accept offers at various fee levels. Again, the
messenger may not share this information with the physicians. 69
The messenger then presents the schedules to payers and solicits offers. Any payer may then make an offer to the physicians in the network. The offer is most likely to be in the form
of a fee schedule. If the messenger negotiates with the payer
over the offers, the process then constitutes a potential illegal
price-fixing arrangement.
The messenger may accept the offer on behalf of any physician who has given the messenger authority to accept offers
within the fee range offered by the payer. The messenger may
also accept on behalf of a physician an offer that is better than
an offer previously accepted by that physician.
Any offer that is not within the fee range authorized by a physician must be forwarded to that physician for acceptance or rejection. The messenger may not exercise discretion about which
offers to forward to physicians. For example, the messenger
may not decide to forgo an offer because it is too low. The messenger may provide objective information to physicians in the
network about a contract offer made to a payer, such as the
meaning of terms and how the offer compares with offers made
by other payers. However, the messenger may not give advice
about whether to accept the offer, and may not inform physicians of those who have accepted or rejected the offer. Finally,
physicians in the network may not communicate with each other
about whether to accept a given offer.
2.

Additional Features that Can Be Included in a Messenger
Model Network
This process appears to be cumbersome, but it can work very
smoothly, especially if the physicians are willing to preauthorize
acceptance of competitive fees that are likely to be offered by
115, 122 (1996). The addition of preauthorization can significantly
enhance the efficiency of a network.
69. This feature, not contained within the 1994 Statements, makes the messenger
model more efficient to operate.
HEALTH MATRIX
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payers. One problem facing a messenger model network is how
to arrive at a competitive fee schedule given that the physicians
are not allowed to communicate with each other and reach
agreements about fee levels. A solution is found in Statements
Five and Six, which allow the network to take a survey of physician fees and costs in the market, and to share that survey with
the physicians if the survey meets certain criteria. The survey
may also be provided to payers.
Physicians may use the survey information to decide at what
rate they want to set their fees. Obviously, each participating
physician has to decide whether to price at a competitive level.
Some may decide to price above the market, and those who find
that they are already below average market levels may decide to
increase their fees. However, those physicians who decide to
price above competitive levels are not likely to receive any offers at that level. The survey will demonstrate why they are not
getting business, and they will have an informed basis upon
which to change their pricing strategy.
If done within the limits set forth in the Statements, development and dissemination of a survey to physicians in a network
will qualify for an antitrust safety zone. Statement Six sets the
criteria for the safety zone:
(1) [The collection of survey data] is managed by a third
party, [such as] a purchaser, government agency, health care
consultant, academic institution, or trade association;
(2) The information provided by survey participants is based
on data more than 3 months old; and
(3) ... at least five providers report[ed] data [for each statistic in the survey,] no individual provider's data represents
more than 25 percent on a weighted basis of that statistic, and
any information disseminated is sufficiently aggregated such
that it would not allow recipients to identify the prices
charged
or compensation paid by any particular provider. 70
The requirement that the data be more than three months old
is especially important. If the fees surveyed are less than three
months old, or if they contain current fees or future fees that
physicians intend to charge, the agencies are likely to consider
the provision of the survey information to physicians as
anticompetitive. 7'
STATEMENTS, supra note 1, at 50.
71. The simple act of providing such information to physicians is not in itself a
violation of the antitrust laws. Illegal price fixing will occur if the physicians then use
that information to price above competitive levels in the market. A violation can

70.
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However, Statement Five sets forth a safety zone that allows
providers to furnish a survey of current fees and costs to payers.
The Statement requires that a survey of current fees or costs
furnished to payers must be taken by a third party, as described
above, to qualify for the safety zone. The messenger may wish
to share the survey with the payers to show that the fees being
offered by participating physicians are competitive with market
levels or are not out of proportion to the costs faced by the
physicians.
Furnishing a survey of future fee-related information to payers is not included in the safety zone. According to Statement
Five, in some circumstances such information might be useful to
a purchaser. Statement Five warns that the collective provision
of future fee-related information may evidence or facilitate a
price-fixing agreement, or it may exert a coercive effect on purchasers by implying or threatening a boycott if the payer does
not agree to the terms being proposed. If future fee-related information is provided to purchasers, it should be gathered and
presented pursuant to the safety zone procedures.
3. Dialogue Over Medical Policy and Non-Fee-Related
Administrative Issues
Statement Four creates a safety zone available to simple networks that wish to collectively gather and present medical data
to payers for the purpose of providing input into the payer's
medical policies. Such data should be directed at improving the
payers' resolution of issues relating to the mode, quality, or efficiency of treatment. The safety zone includes the gathering of
outcomes data and the provision of these data to purchasers as
well as the development of practice parameters and the presentation of these practice parameters to payers.
Physicians in the network can meet and discuss the medical
data, the information that should be provided to a payer, and
the physicians' positions about what constitutes good medical
policy. Representatives of the network may, acting on behalf of
the physicians in the network, have a dialogue with payers about
the implications of the data and practice parameters presented.
occur even if there is no express agreement among the physicians to coordinate their
prices. The communication of the information together with subsequent pricing
above competitive levels will constitute the conspiracy. Using data that is more than
three months old is allowed because it does not necessarily reflect the current charges
of physicians.
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However, the physicians in the network may not collectively
threaten or actually boycott providers who refuse to adopt the
positions advocated by the network.
The safety zone does not include the collective provision of
other types of non-fee-related data to health plans by providers.
However, the provision of non-fee-related data to a payer in an
effort to influence how the payer deals with providers does not
necessarily cause antitrust concerns. Therefore, the Statements
allow a network to gather and present non-fee-related data on
other topics, such as ways to improve the health plan administrative processes that affect the efficiency of the physician's
practice. For example, the network can present a procedure for
verification of benefits and preauthorization of hospital
admissions.
4. Size Limits for the Messenger Model
Finally, messenger model networks can include large numbers
of physicians in a market because they are not reaching agreements with each other on fee schedules. This enables messenger
models to be very marketable to payers who want to have unrestricted access to a large panel of physicians. In addition, a
messenger model need not exclude physicians within a community. 72 When physicians are just starting down the road of network organization, they are often not prepared to organize
networks with limited participation. They are concerned that
such networks would cause bitterness and lack of trust among
the physicians. Therefore, they want the network to be highly
inclusive. This step may be necessary for a medical community
to adapt to managed care without disruption.
B.

Fee-for-Service Networks with Clinical Integration
As with simple networks, there is a need for fee-for-service
networks. Some physicians are willing and able to organize a
network that is capable of more than a simple network, but they
are not ready to enter risk-sharing arrangements such as a capitated agreement. Alternatively, the payers in the market may
not want to share risk because their beneficiaries may not want
to accept the restrictions on choice that often accompany capitation arrangements. In addition, self-funded employers may
want to directly contract with a network, but do not want to
72.

For example, Hypothetical Seven to Statement Eight describes with approval

a messenger model that includes all of the physicians in a small, rural county.
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share risk because the network would then be exposed to insurance regulation. It is expensive and time consuming to obtain
and maintain an insurance license, creating costs that must be
passed on to the employer. In addition, the regulations can affect the design of the employer's benefits program because holders of insurance licenses must comply with state laws mandating
coverage of various health care services.
Therefore, networks and payers, especially self-funded employers, may find it more advantageous to operate on a fee-forservice basis. These networks may be willing and able to include
features designed to reduce the employer's cost and enhance
quality, such as physician credentialing, utilization review, quality assurance, and perhaps other activities. However, as stated
earlier, a network of physicians who agree on the fees to charge
through the network may be engaged in price fixing that is illegal per se, unless it can fit within an exception to the per se rule.
1. Exception From the Per Se Rule for Fee-for-Service
Networks that Do Not Share Risk
The Statements allow a fee-for-service network to be analyzed under the rule of reason if it possesses adequate "clinical
integration" sufficient to demonstrate that (1) the network is
likely to produce significant efficiencies that benefit consumers,
and (2) any price agreements or other restraints that are ordinarily illegal per se among network physicians are reasonably necessary to achieve the efficiencies. It is important to note that the
standard set forth by Statement Eight for proof of efficiencies to
qualify for rule of reason analysis is one of likelihood-the efficiencies need not be proven as an absolute fact.
The problem that physicians and attorneys have in applying
this Statement is knowing when sufficient clinical integration exists to qualify for and pass a rule of reason analysis. To determine this, it is necessary to understand what activities constitute
clinical integration.
2. Techniques Sufficient to Constitute Clinical Integration
Statement Eight states that clinical integration "can be evidenced by the network implementing an active and ongoing program to evaluate and modify practice patterns by the networks'
[sic] physician participants and create a high degree of interdePublished by LAW eCommons, 1997
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pendence and cooperation among the physicians to control costs
and ensure quality. '7 3 Such a program may include:

(1)... [M]echanisms to monitor and control utilization of
health care services that are designed to control costs and assure quality of care;
(2) [The choice of] network physicians who are likely to further these efficiency objectives; and
(3) [T]he significant investment of capital, both monetary
and capability to
and human, in the necessary infrastructure
74
realize the claimed efficiencies.
This description rules out networks that do no more than
achieve transactional efficiencies, such as arranging for broad
geographic and specialty coverage at discounted prices. Transactional efficiencies reduce costs, but are insufficient to affect
the nature and cost, or overall value, of the health care services
delivered by the network. The addition of administrative services such as claims payment is not sufficient either. The agencies
recognize that transactional and administrative efficiencies have
value, but do not believe that the value outweighs the anticompetitive effects of allowing the physicians in the network to
agree on fee levels. This conclusion is in keeping with the agencies' views of transactional efficiencies in joint ventures generally-they are not considered adequate to justify horizontal
price agreements among the participants.75 Networks that rely
on transactional efficiencies must use the messenger model to
arrive at price arrangements with payers. Equally, the addition
of physician credentialing does not suffice. Credentialing establishes the qualifications of physicians, such as their training and
disciplinary and malpractice experience, but it does not do
enough to affect the overall value of the medical care delivered.
A network that implements transactional and administrative
efficiencies, physician credentialing, and preauthorization of
hospital admissions moves into a gray area-it is uncertain
whether the agencies would allow it to be evaluated under the
rule of reason. Such a network would be too similar to the network found to be per se illegal in Arizona v. Maricopa County
Medical Society.76 Although the preauthorization feature of the
73. STATEMENTS, supra note 1, at 72.
74. Id. at 72-73.
75. However, not all commentators and perhaps not all courts agree with the
agencies on this subject. See, e.g., BORK, supra note 21 (arguing that a joint venture
offering transactional efficiencies only should be evaluated by the rule of reason).

76. 457 U.S. 332 (1982).
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network amounts to utilization review, Statement Eight seems
to require more. It says that the process should involve a monitoring of the practice patterns of individual physicians that leads
to a change in their practice patterns to achieve efficiencies. It
should also foster the selection of physicians who further these
efficiency goals. Inclusion of retrospective and concurrent review would probably lead to the same conclusion.
However, if the utilization review features are carried out effectively, the network will be able to deliver a material amount
of efficiencies. It is well established that the use of an effective
preauthorization program by itself provides significant cost savings.77 In addition, the effective use of utilization review does
affect physician practice patterns. Even if physicians are not individually monitored, they learn the conditions under which the
reviewer is likely to deny coverage for care, and should adjust
their practices accordingly. There are likely to be payers who
want to negotiate price arrangements with a fee-for-service network that can deliver these efficiencies. As a result, courts may
find that such a network should be evaluated under the rule of
reason; learned commentators may well agree. While the agencies may be reluctant to affirmatively state that such a network
will qualify for rule of reason analysis, if the network in fact delivers these efficiencies and does not engage in anticompetitive
conduct, it may well be legal.
A feature that may help tip the balance for networks that
have the above characteristics is the adoption or development of
practice guidelines for use by physicians in the network. However, the physicians in the network must apply the practice
guidelines when treating patients, and the guidelines should be
consistent with the protocols applied through the utilization review process. If the guidelines are not used or if they are not
consistent with utilization review procedures, they will not generate efficiencies.
The use of practice guidelines may help qualify a network for
rule of reason analysis because it reflects an effort to have all of
the network physicians follow a best practice. This use, coupled
with a utilization review process targeted at criteria that are con77. Memorandum from Verdon S. Staines to Congressional Budget Office Staff,
The Potential Impact of Certain Forms of Managed Care on Health Care Expenditures 6-7, 19 (Aug., 1992) (on file with the author). See also DAVID C. STAPLETON,
NEW

EVIDENCE ON SAVINGS FROM NETWORK MODELS OF MANAGED CARE, LEWINREPORT TO THE HEALTHCARE LEADERSHIP COUNCIL (May 5, 1994).

VHI, INC.
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sistent with the guidelines, shows that the network is clearly coordinating the care of the physicians to achieve higher quality
and/or lower costs, thereby attempting to distinguish itself from
competitors by developing and applying its own concepts about
how to deliver a good value to patients. Again, even if a network with all of the above characteristics does not monitor individual physicians, it can coordinate 78 care and secure material
efficiencies.
Once a network combines physician practice pattern profiles,
transactional and administrative efficiencies, credentialing,
preauthorization and other utilization review procedures, and
practice guidelines, it should clearly be comprised of sufficient
clinical integration under the Statements. However, the profiling should be used to educate physicians in the network about
how to achieve high-quality, cost-effective care and to terminate
physicians who are persistent overutilizers. Once that dimension is added, the physicians in the network are actively working
with each other to change the nature of the health care they are
delivering. It squarely meets the description of clinical integration in Statement Eight-the network is implementing "an active and ongoing program to evaluate and modify practice
patterns by the network's physician participants and [to] create
among the
a high degree of interdependence and cooperation
79
physicians to control costs and ensure quality.
A network that implements all of the above features and engages in total quality improvement ("TQI") 80 even more clearly
evidences clinical integration. TQI involves the gathering of
data about the total cost of physician performance for treatment
of a given illness or injury and the analyzing of the variations in
cost and outcome. The object is to determine the most effective
process for treating patients for a particular problem, and then
to reduce the variation from that optimal physician performance. It requires that physicians work together to analyze the
data sufficiently to enable them to reliably explain the variations
in performance, and then to develop a protocol for the optimal
78. The addition of primary care physicians as gatekeepers to networks with the
above features would add a degree of explicit coordination among the physicians in
the actual handling of patients. However, gatekeepers are rarely used in a fee-forservice network where there is no risk sharing among the physicians. One of the most
important attributes of fee-for-service networks is a wide choice of physicians for the
patients. Use of gatekeepers is not compatible with that attribute.
79. STATEME rs, supra note 1, at 72.
80. See supra note 57.
http://lawecommons.luc.edu/annals/vol6/iss1/3
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process for treating a problem. When the network uses TQI,
the physicians coordinate at a high level their efforts to reduce
costs and assure high quality.
Such a network also meets the description of a fee-for-service
network in Hypothetical One at the end of Statement Eight,
which network was deemed by the agencies to have adequate
clinical integration. This hypothetical network maintained systems to establish goals relating to quality and appropriate utilization of services by network participants, it regularly evaluated
both the physician participants' individual performance and the
network's aggregate performance with respect to those goals,
where necessary it modified the physicians' actual practices
based on those evaluations, it engaged in case management,
preauthorization of some services, and concurrent and retrospective review of inpatient stays, it developed practice standards and protocols to govern treatment and utilization of
services, and it planned to actively review the care rendered by
each physician in light of these standards and protocols. The
hypothetical network was organized around a core of primary
care physicians and included specialists who were selected based
on their established referral relationships with the primary care
physicians as well as their willingness to cooperate with the
goals of the network and the need to provide convenient services to beneficiaries. Network physicians who failed to adhere
to the network's standards and protocols were subject to remedial action, including expulsion if necessary. Hypothetical One
at the end of Statement Nine describes a physician hospital organization with a similar degree of clinical integration.
3.

The Cost of Clinical Integration

As a network proceeds from transactional efficiencies to TQI,
the administrative work necessary to carry out the functions and
the potential costs of the operation increase. While it is possible
to invest many millions of dollars in electronic data gathering
and analysis systems, as some claim is necessary to achieve
clinical integration, it is also possible to achieve the required
clinical integration through more modest efforts.
The perceptions of attorneys who believe that multimillion
dollar investments are necessary may be based on Hypothetical
One at the end of Statement Eight. The hypothetical network
described with approval made a significant investment of capital, purchasing information systems necessary to gather aggrePublished by LAW eCommons, 1997
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gate and individual data on the cost, quantity, and nature of
services provided or ordered by the network physicians, to measure the performance of the group and the individual physicians
against cost and quality benchmarks, and to monitor patient satisfaction. In addition, the hypothetical network hired a medical
director and support staff to perform these functions and to coordinate patient care in specific cases.
However, the agencies should not require that multimillion
dollar investments be in place before a fee-for-service network
is considered to be clinically integrated. It does not promote the
efficient performance of participants in a market to demand that
they invest large sums of money if such investments are not necessary to achieve the efficiencies that will benefit the market.
This would simply add costs to an industry that is already struggling to become more efficient. In addition, it is unrealistic to
expect a start-up fee-for-service network to have expensive
management assets in place before it has any payer contracts.
The network would have substantial overhead expenses with too
few patients. This would simply assure large losses for a long
period of time.
Instead, the investment in management assets should be in
proportion to the expected volume of the network. In addition,
the network should be able to rely on vendors, such as service
bureaus, hospitals, and payers with an interest in the success of
the network to provide much of the management capacity necessary. Application of this capacity to develop efficiencies
should be handled by physicians in the network.
Service bureaus can be retained to handle many of the administrative aspects of a network. 81 They can also handle
preauthorization and other types of utilization review. This may
be the most cost-effective way to handle these elements of a new
network, as it is not likely to have enough patient volume to
justify hiring an administrative staff. A service bureau's staff
can provide services on a part-time basis. Committees of physicians in the network can review the protocols used by the service bureau to make utilization review decisions, and they can
review how the utilization review process is affecting the quality
81. For a simple article that explains whether to invest in an information system
for these administrative systems or hire a service bureau to handle them, see Peg
Costandino, Technical Considerationsfor Building or Outsourcing Information Sys-

tems for Managed CareApplications, HEALTH
6.
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of care delivered by the network. As the network grows, it can
gradually assume the administrative and utilization review functions itself.
Practice guidelines are available from numerous sources, including medical societies, government agencies, hospitals, payers, and think tanks.82 The network can form committees of
participating physicians to consider what practice guidelines to
adopt, and the committee can decide to modify a guideline from
another source prior to adopting it. Physician committees can
also draft their own guidelines based on data and studies available in the medical literature and their own experiences.
Data on the performance of individual physicians are necessary to engage in profiling. Given that the network operates on
a fee-for-service basis, these can be assembled from claims data.
However, the network does not have to assemble the data and
create the profiles itself. Service bureaus, payers, or hospitals
can perform these functions. Payers in particular are interested
in the network improving its performance, generally have the
ability to assemble claims data, and may be willing to assemble
the profiling data and provide them to the network. Hospitals
may have an interest in the success of the physicians who patronize them.
Further, the profiles do not have to be for every type of service provided by each physician in the network. It is more effective to target a small number of high-volume services that
account for a disproportionate amount of the claims and review
physician performance in handling those services. Limiting the
focus reduces the amount of data that must be gathered and the
cost of assembling the data into profiles. The data review can be
handled by a committee of participating physicians who work
with other physicians in the network to improve their
performance.
Data and analysis for TQI can be handled in a similar way. A
service bureau, payer, or hospital can assemble the data. A hospital may be willing to assemble data if the procedures at issue
are performed on its premises and involve the manner in which
the physicians will direct the hospital staff in the care of the patients. The participating physicians can then analyze the data to
gain a better understanding of the reasons for variation in cost
82. The American Medical Association publishes a directory that lists 1800 practice guidelines developed by 70 physician organizations and other groups.
MED. ASS'N, DIRECTORY OF PRACiCE PARAMETERS
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and outcome and can develop protocols to reduce variation
around a desired quality outcome and cost.
4. The Amount of Physician Investment
Statement Eight also requires that physicians invest significant capital, both monetary and human, in the necessary infrastructure and the capability to realize the claimed efficiencies.
The purpose of this requirement is to assure that the network is
not a sham and that the physicians involved have a stake in the
success of the network as an enterprise. The agencies assume
that if the physicians do not have a stake in its success, the efficiencies might not be achieved, and the network might be used
as a vehicle to coordinate fees among the physicians. This requirement raises the question of how much the network physicians must invest both in the aggregate and on a per-physician
basis to qualify for rule of reason treatment.
The answer to the first question is based upon the discussion
above. The aggregate size of the investment should be in proportion to the expected volume of the network and the cost of
establishing the functions it needs to realize efficiencies. No arbitrary amount of investment should be required. It should be
recognized that a network that finds ways to minimize the investment necessary to carry out the functions that achieve the
efficiencies is performing well. If this can be done by leasing
functions from vendors or receiving contributed functions from
interested parties or equity or contract partners, this should be
allowed. The key requirement for rule of reason qualification is
that the efficiency-enhancing functions are in place and are functioning to achieve the desired efficiencies.
Likewise, there should be no arbitrary amount of money or
time required for a per-physician investment. It should be sufficient to give the physicians involved a stake in the success of the
network as an ongoing enterprise so that they will work to
achieve efficiencies. It may be that a core group of physicians
who do most of the work to organize the network have larger
investments than others. This should be sufficient, as it motivates the core group to get the management systems in place
that are necessary for the network to be successful.

http://lawecommons.luc.edu/annals/vol6/iss1/3

40

1997]

Antitrust
Hirshfeld: Interpreting
the 1996 Guidelines
Federal Antitrust Guidelines for Physician

C. Network PercentageSpecialty Limits
An important issue is what percentage of specialty limits83 will
apply when a network is evaluated under the rule of reason.
This is a critical issue because a network with a large enough
percentage of the physicians in the market may be able to exercise market power, controlling the levels of output and fees.
However, having a large percentage of physicians in a market is
also an important network attribute because purchasers want to
have access to a wide choice of physicians. This is especially
important for fee-for-service networks that rely on unrestricted
access to a wide choice of physicians as a way to differentiate
themselves from capitated networks that may be lower in cost
but that restrict choice.84 Therefore, it becomes important to
balance concerns about market power against the competitive
realities faced by the network.
According to Statement Eight,
merely because a physician network joint venture does not
come within a safety zone in no way indicates that it is unlawful under the antitrust laws. On the contrary, such arrangements may be procompetitive and lawful, and many such
arrangements have received favorable business review letters
or advisory opinions from the agencies.85
The Statements then list in a footnote networks approved by
the DOJ or FTC that accounted for a percentage of given specialties ranging from thirty to fifty percent of the available physicians. The Statements continue: "[P]hysician network joint
ventures in which the physicians share substantial financial risk,
but which involve a higher percentage of physicians in a relevant
market than specified in the safety zones, may be lawful if they
83. See supra section II.
84. In recent years, choice has become an even more important factor as the public became concerned about the quality of care available under health plans. See, e.g.,
The Health Care Revolution-Remaking Medicine in California,L.A. TmEs (14 stories appearing from August 27-31, 1995, reporting the results of a 14-month investigation into managed care); HMOs-What You Don't Know Can Kill You, N.Y. POST
(six stories appearing from September 18-20, 1995); Ellyn E. Spragins, Beware Your
HMO, NEWSWEEK, Oct. 23, 1995, at 54; Erik Larson, The Soul of an HMO, TIME, Jan.
22, 1996, at 44; CBS Evening News With Dan Rather: Eye On America Series on
Health Maintenance Organizations (CBS television broadcast, July 24-26, 1995).
Without reliable information to compare health plan performance, patients rely on
choice as a proxy for quality.
85. STATEMENTS, supra note 1, at 63.
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are not anticompetitive on balance."' 6 While this clarifies that
the agencies may allow such networks, no specific guidance is
provided about maximum percentage limits that will be allowed,
and it does not appear that the agencies have any maximum percentage limits. Instead, they will determine whether a network
is lawful based on the interaction of a variety of factors, including market power. This makes it difficult to predict with precision the reaction of the agencies to a network with greater
concentration percentages than permitted by the safety zone.
The Statements provide several sets of criteria to consider in
evaluating market power, once the concentration of the network
has been determined. These criteria are discussed below.
(1) Exclusive Versus Nonexclusive Networks. Exclusive networks pose a greater danger to competition than nonexclusive
networks because the physicians in an exclusive network are not
able to join competing networks or to contract with health plans
that have not contracted with the network. In this regard, Statement Eight sets forth five criteria for what constitutes a nonexclusive network. 87
(A) Whether "viable competing networks or managed care
plans with adequate physician participation currently exist in the market.... ." If there are no other networks, or
if there are no managed care plans in the market that
have panels of physicians other than the network, then
the agencies may suspect that the network is not truly
nonexclusive.
(B) Whether the "physicians in the network actually individually participate in, or contract with, other networks or
managed care plans, or [whether] there is other evidence
of their willingness and incentive to do so .... ." If the
network physicians do not contract with other networks
or plans, and there is evidence that they are not inclined
to do so, then the network may not be truly nonexclusive.
(C) Whether "physicians in the network earn substantial revenue from other networks or through individual contracts
with managed care plans . . . ." If most of the managed
care revenue earned by network physicians comes from
86. STATEmErs, supra note 1, at 70 n.24; see also Hypotheticals Five and Six at
the end of Statement Eight (describing with approval networks that are substantially
larger than the safety zone limits).
87. The indicia of nonexclusivity are set forth at STATEMENTS, supranote 1, at 6667.
http://lawecommons.luc.edu/annals/vol6/iss1/3
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the network, and not from other networks or managed
care plans, the network may be deemed exclusive.
(D) Whether there are "any indications of significant departicipation from other networks or managed care plans in
the market .... " If the physicians who formed the network have dropped out of other networks or managed
care plans, then the network might not be truly
nonexclusive.
(E) Whether there are "any indications of coordination
among the physicians in the network regarding price or
other competitively significant terms of participation in
other networks or managed care plans." If so, then the
network might not be truly nonexclusive even if the physicians participate in and derive significant amounts of
revenue from other networks or managed care plans, as
the physicians are using the network to arrive at terms of
dealing that they will demand from all payers.
(2) The Availability of Competing Networks. Even if a network is nonexclusive, a large network may have market power if
there are not many other managed care alternatives. If there
are many other options for managed care plans, then it is unlikely that a large network would raise significant competitive
concerns.
(3) The Degree of Competition Facing the Network. The
greater the competition, the more likely the network will actually realize efficiencies and the less likely it is able to exercise
market power. In assessing the competitive environment, the
agencies consider factors such as the number, types, and sizes of
managed care plans operating in the area, the extent of physician participation in those plans, and the economic importance
of the managed care plans to area physicians.
(4) The Extent to Which Different Groups of Physicians in the
Network Have Divergent FinancialInterests. It is possible that
within a network, a small set of "owner" physicians may have
made a larger investment in the network while "contractor"
physicians may have made no investment at all. The owner physicians control and operate the network and have an incentive to
have the network be competitive and successful. The owner
physicians may want the network to contract with the contractor
physicians on the best possible terms so that the network can be
competitive in the market. Therefore, the interests of the owner
and contractor physicians diverge in a way that may prevent
Published by LAW eCommons, 1997
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them from joining in anticompetitive conduct. Under these conditions, it may be possible for a network to be very large,8s as
the motive of the owner physicians will be to offer a wide choice
of physicians to payers, yet not possess market power.
(5) Minimal Possibility of "Spillover" Effects. Spillover effects
occur when the physicians in a network exchange competitive
information to fix prices, divide markets, or engage in other restraints when dealing with payers outside of the network. Spillover can be minimized by setting up structures designed to
minimize the exchange of competitive information among physicians in the network, such as fees. For example, the network
may set a fee schedule based upon an agreement by the physicians to accept the fees negotiated on their behalf by the network, as opposed to having the physicians meet and agree on a
fee schedule to offer. When a network is very large, and the
physicians meet and agree on a fee schedule, there is risk that
the physicians will use that fee schedule as a benchmark for
their dealings with other networks and for individual participation in managed care plans. This can occur even without the
knowledge or intent of the network management.
Spillover effects can also occur when a large network is successful and accounts for a significant portion of the revenues of
physicians in the market. The physicians may start to look to
the network for guidance in deciding with which managed care
plans to deal, simply because it is easier than considering the
merits of each managed care plan that is offered to them. As a
result, physicians in the network may start to turn down con88. See Final Judgment and Competitive Impact Statement, United States v.
Health Choice of Northwest Mo., Inc., Civil Action No. 95-6171-CV-SJ-6 (W.D. Mo.
Sept. 9, 1995); Final Judgment and Competitive Impact Statement, United States v.
Healthcare Partners, Inc., Civil Action No. 395-CV-01946RNC (D. Conn. Sept. 9,

1995). These consent decrees set forth the manner in which the networks involved
could be structured using divergent financial interests. For example, a "qualified
managed care plan" approved in the consent decrees involved networks of physicians

some of whom had significant ownership interests and therefore had an incentive to
see the network succeed. They had a motive to bargain with noninvestor physicians
who contracted to deliver services through the network to obtain their services as
cheaply as possible. By way of further example, many IPAs negotiate financial arrangements with payers on behalf of primary care physicians that gives them an incentive to make minimal use of specialist services. The same IPA negotiates fee
schedules with the same payers on behalf of the specialists. There creates an economic tension between the primary care physicians, who want the specialist care to be
as inexpensive as possible, and the specialists. Under the circumstances of either example, price-fixing conspiracies are unlikely, even though the IPA is negotiating fees

on behalf of specialist physicians. These consent decrees are referred to with approval at STATEMENIS, supra note 1, at 78 n.39.
http://lawecommons.luc.edu/annals/vol6/iss1/3
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tracts from payers who have not contracted with the network or
may ask that managed care plans negotiate with the network
rather than with them individually. This can cause a large network to become exclusive, even though this result is not intended by the network managers.
(6) Rural Settings. It may not be possible to have anything but
a large network in rural settings where there are not enough
providers to form more than one network. The agencies recognize this and are willing to allow such networks if there are sufficient safeguards to prevent anticompetitive conduct.
Hypotheticals Five and Six at the end of Statement Eight describe such networks.
(7) Payer Reaction. Payers such as health plans may want access to a large network of providers. This is most likely to occur
if the payer is trying to enter a market or wants to be able to
offer a wide choice of providers, an attribute frequently desired
by beneficiaries. Positive payer reaction to the formation of a
network will favor its being found legal. s9
In some cases, the determination of whether a network has an
impermissible amount of market power will be obvious upon a
superficial review of the market. Other cases will require a
more detailed analysis. A large network that is likely to survive
a rule of reason analysis is one that has divergent financial interests and procedures to minimize the possibility of spillover effects. Another type of large network likely to survive is one that
is nonexclusive, operates in a competitive market where there
are a number of health plans that have no problems obtaining
physicians to participate on their panels, has procedures to
guard against spillover, and is sought by payers.
D. Direct Contracting with Risk Pool Incentives Without an
Insurance License
Direct contracting between networks and self-funded employers 9° is an opportunity that has drawn a great deal of interest
from networks and employers alike. Since the benefit plans of
these employers are exempt from state insurance regulation
89. Hypotheticals Five and Six at the end of Statement Eight provide examples of
payers who wanted a large network to be formed.

90. Self-funded employers are those who do not purchase insurance to fund their
employee health benefits plans; instead they pay for health benefits plans themselves.
For a more detailed description, see supra note 14.
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under ERISA, 91 self-funded employers do not have to incur the
cost of complying with state regulations, including paying premium taxes, meeting solvency standards, providing mandated
benefits, and offering community-rated premiums. 92 These costs
are significant, and employers have been able to save substantial
amounts by becoming self funded. They may also be able to
achieve savings by eliminating the profit margin of insurers.
However, most self-funded plans are administered by insurers
because employers do not have the capacity to administer their
benefits plans. Since insurers profit on the administration of
plans, it is uncertain whether self-funding results in savings
above those achieved by avoiding state regulation. However,
the insurer administering a self-funded plan can implement costsaving managed care techniques; it can contract with physicians
to serve the self-funded plan, obtain discounts, and secure
agreements to participate in utilization review programs operated by the insurer on behalf of the employer.
Direct contracting occurs when a network (organized by physicians as opposed to an insurer) contracts with a self-funded
employer to deliver health care that will be needed by the employees who are covered by the employer. Self-funded employers are interested in contracting with networks to obtain access
to cost-effective health care without having to organize and administer their own networks of physicians. Physicians have become interested in direct contracting because it provides them
with more autonomy over patient care and the economics of
their medical practice.
Most self-funded employee benefit plans are fee-for-service
options-that is, indemnity plans or preferred provider organizations. Until the Statements were issued, it was legally perilous
for networks to engage in direct contracting on a fee-for-service
basis unless the physicians arrived at fee arrangements using the
messenger model. Arrangements between the physicians and
employees for agreed-upon discounted fees were likely to be
categorized as illegal price-fixing arrangements. Now, Statement Eight enables networks to engage in direct contracting on
a fee-for-service basis because it allows for the messenger model
as well as clinically integrated fee-for-service networks.
91. 29 U.S.C. § 1144 (1994).
92. Licensed insurers bear these costs directly when an employer purchases insurance, but then pass these costs on to the employers, their customers.
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Health maintenance organization ("HMO") options offered
by employers are generally not self-funded. Instead, they are
underwritten by state-licensed HMOs, and the cost of complying
with state regulations is passed on to the employers. In recent
years, employers have become more interested in directly contracting with physicians on a risk-sharing basis, such as through
capitation. This would enable the employer to avoid the cost of
HMO state regulation.
However, a network that engages in risk sharing with an employer by entering into capitation arrangements without obtaining a state insurance license may run afoul of states'
insurance laws. Most states have concluded that the act of offering capitation to an employer constitutes the business of insurance. 9 3 State insurance commissioners argue that capitation
involves the sharing and spreading of risk, which is the essence
of what constitutes an insurance arrangement subject to state
regulation. 94
However, the agencies created a safety zone, providing an opportunity for networks to engage in direct contracting in a way
that allows them to share in the rewards of achieving savings in
risk pools and to reap the benefits of a global capitation arrangement with an employer without obtaining an insurance license. To do this, the Statements establish the following
category of substantial financial risk:
[U]se by the venture of significant financial incentives for its
physician participants, as a group, to achieve specified costcontainment goals... [including] ... establishing overall cost

or utilization targets for the network as a whole, with the network's physician participants subject to subsequent substantial
rewards or penalties based on group performance in meeting
the targets .... 95
93. Most state insurance commissioners require that provider networks that share
risk directly with a self-funded employer obtain an insurance license. Overbay &
Hall, supra note 16, at 364. See also Shipley, supra note 16. There are some exceptions. For example, the State of Illinois does not require a license if the employer
continues to assume ultimate responsibility for providing the benefits to employees in

the event that the provider group becomes insolvent.

DAVID GRANT, ILLINOIS DEP'T
OF INS., PROVIDER BASED MARKET SYSTEMS: WHEN TO REGULATE (1996). The at-

tomey general of North Carolina has rendered an opinion agreeing with Illinois.
Durham County Hosp. Corp., Advisory Opinion: Contracting with Self-Insured Employee Benefit Plans and Health Care Providers (written by Jenn R. McArthur, Chief
Counsel, & Andrew A. Vanore, Jr. to John L. Crill) (Oct. 9, 1996) (on file with the
author).
94. Overbay & Hall, supra note 16, at 369-74.
95. STATEMENTS, supra note'1, at 69.
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The Statements do not clearly express whether a network
would be subject to substantial financial risk sharing, and therefore fall within the safety zone, if it provides rewards but does
not impose penalties. However, under the logic of this defined
category of substantial financial risk, the arrangement should
qualify for a safety zone if the bonus is substantial enough to
provide a significant financial incentive for the physicians to
achieve the specified cost-containment goals. Use of the reward-only arrangement should prevent the network from being
categorized as an insurer by a state insurance commissioner because there is no downside risk that is being underwritten by the
network that could cause insolvency if not appropriately
managed. 96
The arrangement could work in the following way. All of the
physicians could agree to a discounted fee schedule whereby
their usual fees would be discounted by an average of twentyfive percent. The physicians would also agree to predetermined
budgets with a payer based upon the payer's historical experience. The budget would be broken down into several components, including a physician component, a hospital component,
and a pharmaceutical component. If the physicians meet the aggregate budget, they would be entitled to a bonus of ten percent
of their fees. If they would come in below any budget, they
would get a bonus of fifty percent of the savings. If they would
beat some budgets but come over budget on others, the amount
saved would be offset by the amount overspent. The physicians
would substantially invest in and donate time to the operation of
a utilization and quality control system that could enable them
to manage costs sufficiently to qualify for the bonus.
The arrangement described above should fall within the definition of substantial financial risk set forth in Statement Eight.
To fall within a safety zone, the network must also meet the applicable specialty percentage size limits. This type of arrangement would fall within a safety zone because it is assumed that
the physicians in the network must be clinically integrated and
achieve efficiencies in order to reap the rewards, and it is assumed that these rewards give them an incentive to engage in
clinical integration and in fact achieve the efficiencies.
96. There are limits to this argument. If, for example, a network agrees on fees
that are so highly discounted that they must receive the reward in order to break even
and make a profit, then the agreement is vulnerable to being categorized as an insurance arrangement.
http://lawecommons.luc.edu/annals/vol6/iss1/3
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Commentators believe that this type of arrangement is the
key to achieving the ultimate promise of managed care. This
promise boasts of significantly enhancing the quality of
medicine while simultaneously reducing its cost by coordinating
the efforts of multiple providers in the care of a patient. These
commentators believe the promise can be achieved by networks
that (1) use total quality improvement techniques to analyze
both their outcomes and the resources used to achieve these
outcomes, and (2) use the results of this analysis to develop protocols designed to achieve the best possible outcomes using the
least possible resources. 97 Some believe that these techniques
are most likely to be used successfully if implemented by networks that compete for the business of self-funded employers. 9
CONCLUSION

The Statements provide significant opportunities for providers to form joint venture health care delivery networks. Interpretation of the Statements requires the exercise of judgment
based upon a foundation of knowledge about joint venture analysis under federal antitrust laws. While the exercise of judgment
lacks the type of precision that may make clients feel more comfortable, a well-informed attorney can provide opinions with a
reasonable degree of confidence.

97. See, e.g., Peter Boland, The Role of Reengineering in Healthcare Delivery, in
3 (Peter Boland ed., 1996); WALTER A.
ZELMAN, THE CHANGING HEALTH CARE MARKETPLACE 81-83 (1996).
REDESIGNING HEALTHCARE DELIVERY

98.

For example, the Buyers Health Care Action Group ("BHCAG"), a buyers'

coalition in Minneapolis, Minnesota, is experimenting with a direct contracting program where provider networks compete with each other for the business of the coalition. BHCAG is conducting the experiment because it believes that provider
networks in competition with each other for the business of employers are most likely
to realize the promise of managed care. Thomas Allen, Applying Market Power-The
BHCAG isFlexing its Muscle, 77 MINN.MED. 6 (1994).
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